Delivery Order 75N92022D00016-75N92022F00001

Award Date 9/28/22
Potential Completion Date 11/15/24
Potential Value $18M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Nashville, TN 37228, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Aegis Sciences Corporation, a forensic toxicology and healthcare laboratory company, for a Test Surge and Data Sharing multiple-award indefinite-delivery, indefinite-quantity (IDIQ) contract. The delivery order, valued at $610,000.00, will task Aegis to provide science-driven drug testing and consulting services, including COVID-19 testing, genomic sequencing, and variant tracking out of its Nashville,...
The Centers for Disease Control and Prevention (CDC) awarded a $39.9 million firm fixed price definitive contract to Aegis Sciences Corporation for COVID-19 genome sequencing services. As the prime contractor, Aegis Sciences Corporation will perform the sequencing work out of its Nashville, Tennessee laboratory. The one year contract is intended to support the CDC's ongoing efforts to track genetic variations of the SARS-CoV-2 virus through genomic surveillance. No subcontractors or set aside...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Agena Bioscience, Inc., a for-profit corporation that provides genomic testing equipment, reagents, and services. The contract, valued at $77,553.00, is for the delivery of IPLEX GOLD, PCR REAGENT AND SPECTROCHIP KIT. Agena Bioscience has previously provided similar genomic testing supplies and equipment to federal agencies like the CDC and Department of Veterans Affairs through past...
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Agena Bioscience, Inc., a for-profit corporation that provides genomic testing equipment, reagents, and services. The $184,270.00 award is for the provision of AGENA MASSARRAY LAB EQUIPMENT, to be completed by August 30, 2021. Agena Bioscience has previously provided genomic testing supplies and equipment to support public health genomics research and...
This is a $13,875 firm-fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the U.S. Department of Health and Human Services, to The Johns Hopkins University to provide high-throughput genotyping and DNA sequencing services for studying the genetic contributions to human health and disease. The work is part of the Global Diversity Array + PGx (pharmacogenomics) initiative for NHGRI. The contract has an ultimate completion date of...
The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency under the Department of Health and Human Services, awarded a $14,528.22 firm fixed price purchase order to Genesee Scientific LLC, doing business as Genesee Scientific Corp, to provide a real-time thermocycler. This equipment will be used to validate genes in patient samples and establish potential pathways that result in the final inflammatory and coagulative status of these patients. The award, which has an ultimate...
This is a $145,000.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the Translational Genomics Research Institute (TGen), a non-profit research organization. The contract is for RUN DATA SAMPLES services, with a completion date of September 29, 2024. TGen has previously performed genomic research services for federal agencies under both contracts and grants, including work related to SARS-CoV-2,...
This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the Translational Genomics Research Institute (TGen), a non-profit research organization. The contract, valued at $109,504.00, is a Definitive Contract with a Firm Fixed Price under Broad Agency Announcement (BAA) 2017. The contract does not have a set-aside designation. Under this contract, TGen will provide a variety of genomic research services, including SARS-CoV-2...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to ACGT Inc. for DNA sequencing services. The $10,000 contract is for DNA sequencing of human antibodies, with a period of performance through October 30, 2015. ACGT Inc. is a for-profit, Asian-Pacific American-owned S corporation that provides a range of DNA sequencing and molecular biology services to government,...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $12,105.91 firm fixed price delivery order to Illumina, Inc. to provide DNA sequencing and genomics core requirements including Illumina library preparation kits. The place of performance is San Diego, California. The period of performance is from June 30, 2023 through September 29, 2023. The award supports the agency's biomedical research efforts by providing key...
  • 75N92022D00016
    Indefinite Delivery Contract
  • 75N92022D00016-75N92022F00001
    Delivery Order

This firm fixed price delivery order was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Aegis Sciences Corporation, a for-profit organization, to provide genotyping services for tracking viral variants. The order, valued at $17,771,325.00, is a task order under an existing indefinite delivery contract between NHLBI and Aegis potentially worth $47.97 million to perform viral variant genotyping work. The work will be conducted at Aegis' facility in Nashville, Tennessee from September 2022 through April 2024. No set-aside was used for this award. Aegis is an established provider of forensic toxicology, drug testing, and COVID-19 related services, having received prior prime contracts from agencies such as the National Institutes of Health and Centers for Disease Control and Prevention.

Generated 9/6/24, 9:31 AM